PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
27-Aug-2024 European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara® (ustekinumab), for the treatment of multiple chronic inflammatory diseases Celltrion
27-Aug-2024 UCB to Accelerate Innovation and Strategic Partnerships, Divesting Mature Product Portfolio in China UCB
27-Aug-2024 Medigene AG implements announced 2:1 share capital reduction and consolidation of the shares effective August 29, 2024 Medigene AG
27-Aug-2024 RedHill’s Opaganib Granted Orphan Drug Designation by the FDA for Childhood Cancer, Neuroblastoma RedHill Biopharma
27-Aug-2024 Regeneron Receives EC Approval for Ordspono (odronextamab) to Treat R/R Follicular Lymphoma or R/R Diffuse Large B-cell Lymphoma Regeneron
27-Aug-2024 Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies Microbiotica
27-Aug-2024 ENA Respiratory Progresses Phase Ib Study of its Dry Powder Formulation of Intranasal Innate Immunomodulator INNA-051 ENA Respiratory
27-Aug-2024 Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 Published in JITC Transgene
27-Aug-2024 New drug trial offers hope to 200,000 people with ‘hidden’ lung condition EMBARC
27-Aug-2024 Multi Cancer Early Detection Market Set to Reach USD 5.1 Billion by 2034 Prophecy Market Insights
23-Aug-2024 Cherwell to spotlight Delivering Knowledge initiative at PHSS Annual Conference 2024 Cherwell
23-Aug-2024 Biologics CDMO Market Size to Grow at 11.80% CAGR Prophecy Market Insights
22-Aug-2024 DATA SUPPORTING FDA APPROVAL PUBLISHED IN HIGH-IMPACT JOURNAL ANGLE plc
22-Aug-2024 PureTech Appoints Michele Holcomb, PhD, to Board of Directors PureTech Health plc
22-Aug-2024 Unaudited Interim Results for the six months ended 30 June 2024 Cambridge Cognition Holdings plc
22-Aug-2024 Hevolution Foundation and Dolby Family Ventures join Vandria’s 2nd Series A closing, bringing the total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer VNA-318 into CNS Clinical Development Vandria SA
22-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics Ltd
22-Aug-2024 London BioScience Innovation Centre welcomes Baseimmune Ltd to its new fully fitted grow-on lab space within the Apex Building London BioScience Innovation Centre
22-Aug-2024 RedHill Announces Positive Obesity and Diabetes Results with Opaganib RedHill Biopharma
22-Aug-2024 Cumulus Oncology and leadXpro Achieve Critical Milestone in GPR68 Drug Discovery Project Cumulus Oncology